Phase I safety and antigenicity of TA-GW: a rebombinant HPV 6 L2E7 vaccine for the treatment of genital warts. - Thompson,H.S.; Davies,M.L.; Holding,F.P.; Fallon,R.E.; Mann,A.E.; O'Neill,T.; Roberts,J.S. (Vaccine, 1999)